Gina Lesnik
Family Medicine · Aurora, ILNPI 1164418653
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $9,441 of the $10,557 with a category attached, or 89.4%. 35 manufacturers reported payments, led by AbbVie at 59.6% of the total. Reporting peaked in 2022 at $2,857 and has fallen 71.7% since, to $807 in 2025. Among family medicine clinicians in IL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 472 payments — averaging $22.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$6K
- Amgen$500
- Boehringer Ingelheim$439
- Lilly USA, LLC$393
- Merz North America, Inc.$369
- Novo Nordisk$366
- plus $2K from 29 others
What the payments were for
- Consulting fees$9989%
- Food & beverage$9,44189%
- Education$1191%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 231 | $6,288 |
| Amgen | 27 | $500 |
| Boehringer Ingelheim | 24 | $439 |
| Lilly USA, LLC | 33 | $393 |
| Merz North America, Inc. | 3 | $369 |
| Novo Nordisk | 26 | $366 |
| AstraZeneca | 23 | $365 |
| Johnson & Johnson | 16 | $299 |
| Pfizer | 13 | $245 |
| Galderma Laboratories, L.p. | 6 | $196 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 13 | $160 |
| Sanofi-aventis U.S. LLC | 8 | $126 |
| Biohaven Pharmaceutical Holding Company Ltd. | 6 | $119 |
| Teva Pharmaceuticals USA, Inc. | 7 | $115 |
| Abbott | 4 | $78 |
| GSK | 4 | $55 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $50 |
| Astellas Pharma US Inc | 3 | $45 |
| Ironshore Pharmaceuticals Inc. | 2 | $40 |
| Shire North American Group Inc | 2 | $39 |
| E.r. Squibb & Sons, L.L.C. | 2 | $30 |
| Merck | 2 | $28 |
| Philips North America LLC | 1 | $24 |
| Novartis | 1 | $22 |
| Dexcom, Inc. | 1 | $20 |
| Genentech USA, Inc. | 1 | $18 |
| Biohaven Pharmaceuticals, Inc. | 1 | $18 |
| Mylan Specialty L.p. | 1 | $17 |
| Bayer | 1 | $17 |
| Cranial Technologies, Inc | 1 | $15 |
| Eisai Inc. | 1 | $15 |
| Impel Pharmaceuticals Inc. | 1 | $14 |
| Romark Laboratories, LC | 1 | $13 |
| Nalpropion Pharmaceuticals LLC | 1 | $11 |
| Arbor Pharmaceuticals, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$10,557 in reported general payments places this provider in the 95th percentile of 4,116 family medicine providers in Illinois.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ProgesteroneProgesterone, Micronized | 16 | $1,014 |
| Ultra-Fine Mini Pen NeedlePen Needle, Diabetic | 11 | $647 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Aurora
- Frank PhillipsChicago$1.6M
- Peter TothSterling$1.4M
- Bradley TorphyChicago$1.3M
- Jeffrey RoyceRockford$890K
- Anthony AuriemmaWestmont$788K
- Manfred ManGurnee$764K
- Barbara BellarOakbrook Terrace$599K
- Bernie RancheroAltamont$533K
- Sandy GibsonChicago$309K
- Mandy GittlerChicago$204K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.